Disposition and Follow Up
• In consultation with David Abramson, Chief of Ophthalmic Oncology at Memorial Sloan-Kettering Cancer Center in NY, the decision in this case was to follow the patient every three months without intervention.2
• Follow-up includes fundus photography, and spectral domain OCT, panoramic imaging with optomap® (including analysis of red and green laser separation), and B-scan ultrasound.
• Over the past two years, no change has been noted in the appearance, size and thickness of the lesion.
An affordable b-scan ultrasound- the Scanmate- is now available through DGH.
